Microbot Medical Inc. (MBOT) › Cash & EquivalentsMicrobot Medical Inc. (MBOT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $30.04M2009: $38.62M2010: $19.71M2011: $13.31M2012: $8.47M2013: $30.59M2014: $791.0K2015: $437.0K2016: $2.71M2017: $10.79M2018: $5.24M2019: $28.77M2020: $19.65M2021: $13.49M2022: $2.44M2023: $2.47M2024: $3.11M2025: $3.91M$3.91M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$3.91M+25.6%2024$3.11M+26.2%2023$2.47M+1.1%2022$2.44M-81.9%2021$13.49M-31.3%2020$19.65M-31.7%2019$28.77M+449.3%2018$5.24M-51.4%2017$10.79M+298.2%2016$2.71M+519.9%2015$437.0K-44.8%2014$791.0K-97.4%2013$30.59M+261.0%2012$8.47M-36.4%2011$13.31M-32.5%2010$19.71M-49.0%2009$38.62M+28.5%2008$30.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share